It's applicable as I was responding to a post saying short squeezes don't happen in biotech. Fundamentally, a high OS isn't as important as the short interest ratio when it comes to short squeezes. We have 1.6 billion shares OS but average daily volume of around 4 million. We have extremely low turnover. The ratio is at 9. That's why I believe a short squeeze is likely.